CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

Recent TAU study demonstrates how a crucial but underexplored process of DNA transfer between bacteria affects its defense ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it ...

To prepare students for the challenges and opportunities of an increasingly AI-driven world, Connecticut College has launched ...

The colder months have become synonymous with an uptick in respiratory illnesses like the flu and RSV and this winter is no ...

The Cambridge Police Department said they responded to a crash on Clarendon Avenue involving two cars and property damage, ...

For years, attempts have been made to cure type 1 diabetes, in which sufferers are dependent on insulin injections as soon as ...